In Brief: Immunomedics' LeukoScan
This article was originally published in The Gray Sheet
Executive Summary
Immunomedics' LeukoScan: Infectious disease imaging agent for use in detecting and diagnosing osteomyelitis (bone infection) involving long bones is cleared for marketing in European Union countries. The approved indication applies particularly to patients with diabetic foot ulcers. A biologic license application is pending at FDA to support use of the radiolabeled monoclonal antibody fragment for the same indication as that approved in the EU, as well as for use in detecting acute atypical appendicitis...